CURIS, INC. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
CURIS, INC. (CRIS) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 0.27% for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-13.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2013-03-13
- CURIS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2012 was 0.27%, a 32.50% decline from fiscal 2011.
- CURIS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2011 was 0.40%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month |
|---|---|
| 2012-12-31 | 0.27% 10-K · filed 2013-03-13 |
| 2011-12-31 | 0.40% 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |